about
New susceptibility loci associated with kidney disease in type 1 diabetes.Low birth weight does not increase the risk of nephropathy in Finnish type 1 diabetic patients.Adult stature and diabetes complications in patients with type 1 diabetes: the FinnDiane Study and the diabetes control and complications trial.Arterial stiffness and vascular complications in patients with type 1 diabetes: the Finnish Diabetic Nephropathy (FinnDiane) Study.Association between testosterone, estradiol and sex hormone binding globulin levels in men with type 1 diabetes with nephropathy.Competing-risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria.The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes.Pulse pressure predicts incident cardiovascular disease but not diabetic nephropathy in patients with type 1 diabetes (The FinnDiane Study).The Presence and Consequence of Nonalbuminuric Chronic Kidney Disease in Patients With Type 1 Diabetes.Association testing of previously reported variants in a large case-control meta-analysis of diabetic nephropathy.Serum concentration of cystatin C and risk of end-stage renal disease in diabetes.Metabolic phenotypes, vascular complications, and premature deaths in a population of 4,197 patients with type 1 diabetesUrinary liver-type fatty acid-binding protein and progression of diabetic nephropathy in type 1 diabetes.Effect of parental type 2 diabetes on offspring with type 1 diabetesMetabolic syndrome as a risk factor for cardiovascular disease, mortality, and progression of diabetic nephropathy in type 1 diabetes.The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetesSubarachnoid hemorrhage in type 1 diabetes: a prospective cohort study of 4,083 patients with diabetesIncidence of stroke according to presence of diabetic nephropathy and severe diabetic retinopathy in patients with type 1 diabetesNetwork of vascular diseases, death and biochemical characteristics in a set of 4,197 patients with type 1 diabetes (the FinnDiane Study).A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes.The association between macronutrient intake and the metabolic syndrome and its components in type 1 diabetes.Diabetes mellitus and ischemic stroke in the young: clinical features and long-term prognosis.Leisure-time physical activity and development and progression of diabetic nephropathy in type 1 diabetes: the FinnDiane Study.Kidney injury molecule-1 and the loss of kidney function in diabetic nephropathy: a likely causal link in patients with type 1 diabetes.Metabolic diversity of progressive kidney disease in 325 patients with type 1 diabetes (the FinnDiane Study).Lipid abnormalities predict progression of renal disease in patients with type 1 diabetes.Different lipid variables predict incident coronary artery disease in patients with type 1 diabetes with or without diabetic nephropathy: the FinnDiane study.Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study).Triglyceride-cholesterol imbalance across lipoprotein subclasses predicts diabetic kidney disease and mortality in type 1 diabetes: the FinnDiane Study.Association of dietary sodium intake with atherogenesis in experimental diabetes and with cardiovascular disease in patients with Type 1 diabetes.Clustering of risk factors in parents of patients with type 1 diabetes and nephropathy.Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes.Physical Activity Reduces Risk of Premature Mortality in Patients With Type 1 Diabetes With and Without Kidney Disease.Prognosis and Its Predictors After Incident Stroke in Patients With Type 1 Diabetes.Different risk factor profiles for ischemic and hemorrhagic stroke in type 1 diabetes mellitus.Depression is associated with the metabolic syndrome among patients with type 1 diabetes.Diabetes and intracerebral hemorrhage: Baseline characteristics and mortality.Regression of albuminuria and its association with incident cardiovascular outcomes and mortality in type 1 diabetes: the FinnDiane Study.Urinary liver-type fatty acid binding protein is an independent predictor of stroke and mortality in individuals with type 1 diabetes.Frequent and intensive physical activity reduces risk of cardiovascular events in type 1 diabetes.
P50
Q29417066-BB30A6A6-1396-4378-8263-3C74B9ED4FADQ33243530-8C2016E1-FD5C-4927-B3A7-DDC436980708Q33459001-78ED6097-539C-4B30-A4E7-D3C956F96BC9Q33736980-AD2214D2-E7D4-4968-8C0F-74A750303D08Q33940015-76B73863-6A98-4A9F-9103-A24437047C73Q34695419-1006F523-8BC7-42DE-B2E2-550C0C3DF0B9Q34718385-FC2FA7F1-FF28-49CB-A687-7B064DA18118Q34718404-FB306840-1B2A-4A81-9552-B6E37E846B84Q35756638-72D5E1CD-CD0B-4307-84B0-910F616DCF7BQ36109264-C54C541F-5E25-4E2E-A66A-FB66E0E0FF66Q36334563-5E2A95AE-8529-4322-82D3-398778AA4F7FQ36842641-69EB3207-927E-4586-B431-306FDFF821CDQ36942114-C9DF3326-E4FA-45E3-9519-C88FF8C220CFQ37022883-F040910C-A3B2-42C8-8FAD-260B9C14ABCCQ37163795-F3DFA39C-C2CD-43CB-90AC-AADF2756D14AQ37236230-A4D61759-20B4-4C62-93E9-E5214DDECB8FQ37278178-4B99FA63-1D7E-40BE-9BE8-B0080E68FF28Q37331371-A3B17A5B-B39B-4AB6-8CD5-B7B3D9E57C3CQ37392018-81326478-B24C-443C-BF21-FDD017824504Q37400773-CF66BD52-2E80-4EFA-907B-4AFC615F6630Q38953482-3AFBA47F-BFFC-4977-AF4D-77014920E58BQ39747194-19C0F955-7D57-42DC-8B71-35C90F4E1EB8Q41508250-4742B9B7-1E32-4AD4-AD5B-15883DE062B6Q42154137-73D8FF3C-5527-4630-A364-2E30A4C4A008Q42630426-26233F3C-C616-4B9F-972E-F3A6C88AFEA8Q43264761-87629319-96E5-41DC-820B-3D33A5871FC2Q43492278-E2FC46F8-D51F-49BF-AAB6-706BE956972DQ44248797-EE20FA86-AA92-4567-8FD5-F617F41DE269Q45145247-9DF94E98-1CC7-4872-95F6-D4A3B74E5004Q46335942-DC564572-6131-4AA3-BC95-0A5A9295F55EQ46339931-CC949CBE-E535-4AF7-B1CC-21DA8BA96701Q46696577-FB8ADA22-EAA9-4A75-B3A8-C5F189E11DA1Q48179234-EFA91CB8-1952-4A27-B4B5-8D7B48FD4F17Q48235472-875CFCEB-2B96-4973-8811-A44617448341Q48638102-C1E4FDE7-C090-407D-B8B3-9D57DFE47C86Q49115705-1439E83A-426A-4E28-A015-0F52E5DD8FC9Q50005354-F2DD104B-25C9-44F5-94D1-DA5757C3F82CQ50104171-FC8F9C9B-112C-4A06-92BE-C115182CB1C6Q50950531-7D72B4F2-C1AC-4A3B-BA63-BB3F72C6F6D9Q50990745-286AFB31-A9DE-4C50-9C79-009600EF319B
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Lena M Thorn
@ast
Lena M Thorn
@en
Lena M Thorn
@es
Lena M Thorn
@nl
type
label
Lena M Thorn
@ast
Lena M Thorn
@en
Lena M Thorn
@es
Lena M Thorn
@nl
prefLabel
Lena M Thorn
@ast
Lena M Thorn
@en
Lena M Thorn
@es
Lena M Thorn
@nl
P106
P21
P31
P496
0000-0003-3999-0390